Post-COVID-19 Intestinal and Mesenteric Mucormycosis
- PMID: 34730420
- PMCID: PMC10372510
- DOI: 10.1177/00031348211048841
Post-COVID-19 Intestinal and Mesenteric Mucormycosis
Abstract
A thirty-eight-year-old uncontrolled diabetic with a recent COVID-19 infection presented with extensive bowel ischemia and gangrene with a microscopic diagnosis of intestinal and mesenteric mucormycosis. Although there are a few reported cases of primary gastrointestinal mucormycosis, our case showing involvement of the intestine and/or mesentery, that too in a post-COVID patient, is quite uncommon. The immunosuppressive effect of the COVID-19 disease, uncontrolled diabetes, and the use of corticosteroids for the treatment of severe COVID are the most probable reasons for the emergence of severe opportunistic infections, both as a coinfection and as a sequalae to COVID.
Keywords: COVID-19; gastrointestinal; mucormycosis; opportunistic infections in COVID.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019;19(12):e405-e421. doi:10.1016/S1473-3099(19)30312-3Epub 2019 Nov 5. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
